2797253

Source:http://linkedlifedata.com/resource/pubmed/id/2797253

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006463, umls-concept:C0151763, umls-concept:C1524063
pubmed:issue	30
pubmed:dateCreated	1989-11-9
pubmed:abstractText	A man aged 57 years with a chronic megakaryocytic granulocytic myelosis, treated with an intermittent low-dose busulfan schedule, developed intrahepatic cholestasis. We advise to do liver biopsy, if possible, to differentiate between busulfan hepatotoxicity and leukaemic activity. In the former case, it may be necessary to stop busulfan.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/2797253
pubmed:language	dut
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0400770
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Busulfan
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0028-2162
pubmed:author	pubmed-author:AdangR PRP, pubmed-author:BreedW PWP
pubmed:issnType	Print
pubmed:day	29
pubmed:volume	133
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1515-8
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:2797253-Busulfan, pubmed-meshheading:2797253-Cholestasis, Intrahepatic, pubmed-meshheading:2797253-Drug-Induced Liver Injury, pubmed-meshheading:2797253-Humans, pubmed-meshheading:2797253-Male, pubmed-meshheading:2797253-Middle Aged, pubmed-meshheading:2797253-Primary Myelofibrosis
pubmed:year	1989
pubmed:articleTitle	[Liver damage during use of busulfan].
pubmed:publicationType	Journal Article, English Abstract, Case Reports